| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/18/1991 | CA2034246A1 Atropine-salbutamol aerosol |
| 07/17/1991 | EP0437406A1 Pharmaceutical composition in stable aqueous suspension form containing sucralfate and anti-acidic substance as well as process for preparing it |
| 07/17/1991 | EP0437388A1 Method for incorporating in pellets active substances protected against degradation in the rumen of ruminants |
| 07/17/1991 | EP0437368A1 Fluid ophthalmic composition based on lipid microparticles containing at least one active principle |
| 07/17/1991 | EP0437294A1 Oral pharmaceutical compositions in unit dosage form |
| 07/17/1991 | EP0437225A1 Topical preparations |
| 07/17/1991 | EP0437098A2 Compressed confectionery tablets with at least two phases and sequential flavour delivery system |
| 07/17/1991 | EP0437025A2 Compositions containing aldose reductase inhibitors for the treatment of ulcers |
| 07/17/1991 | EP0436786A2 Process and apparatus for extruding pellets |
| 07/17/1991 | EP0436729A1 Microcapsule, treatment liquid containing microcapsules, and textile structure having microcapsules stuck thereto |
| 07/17/1991 | EP0436726A1 Method of photostabilizing eyewash |
| 07/17/1991 | EP0436667A1 Biodegradable in-situ forming implants. |
| 07/17/1991 | EP0436650A1 Hydrated lipidic lamellar phases or liposomes based on ecdysteroids. |
| 07/17/1991 | EP0436631A1 Method and composition for the treatment of burns. |
| 07/17/1991 | EP0414663A4 Liposome continuous size reduction method and apparatus |
| 07/17/1991 | EP0340307A4 Composition of polymer diffusion matrix for transdermally introducing pharmaceutical substances |
| 07/17/1991 | EP0149600B1 Compositions for treating keratosis |
| 07/17/1991 | CN1053090A Process for preparing mixture of ribonucleotides |
| 07/17/1991 | CN1053010A Pharmaceutical preparation |
| 07/16/1991 | US5032617 Substituted benzamide radiosensitizers |
| 07/16/1991 | US5032585 Antiulcer, respiratory system disorders |
| 07/16/1991 | US5032582 Method for treating fungal infections with amphotericin B/cholesterol sulfate composition |
| 07/16/1991 | US5032572 Polymers containing cross-linked azo bonds, which polymers are useful for releasing therapeutic agents into the lower gastrointestinal tract |
| 07/16/1991 | US5032457 Anionic surfactants, zwitterions |
| 07/16/1991 | US5032408 Paraffin oil, glycerides, pancreas or thymus extreact, quaternized montmorillonite, preservative |
| 07/16/1991 | US5032406 Sustained release |
| 07/16/1991 | US5032405 Oral pharmaceutical composition for acid sensitive proteinaceous agents |
| 07/16/1991 | US5032404 Fungicides |
| 07/16/1991 | US5032403 Multilayer plaster |
| 07/16/1991 | US5032401 Glucan drug delivery system and adjuvant |
| 07/16/1991 | US5032393 Ranitidine flavor masking |
| 07/16/1991 | US5032392 Vitamin A, antioxidant, chelate agent |
| 07/16/1991 | US5032384 Tocopherol and ketoprofen, peridontal diseases |
| 07/16/1991 | US5032207 One-step method for forming a pressure-sensitive adhesive transdermal drug device |
| 07/16/1991 | US5032109 Drug delivery |
| 07/16/1991 | US5032074 Apparatus for manufacturing hard capsules for medicament use |
| 07/16/1991 | CA1286229C Pseudoephedrine dosage form |
| 07/16/1991 | CA1286227C Externally applicable, antiviral pharmaceutical composition accumulating in the skin and process for the preparation of same |
| 07/16/1991 | CA1286225C Medicament for the treatment of inflammations of the eye |
| 07/16/1991 | CA1286067C Method of manufacturing hard capsules for medicament use and apparatus of manufacturing them |
| 07/16/1991 | CA1286065C Formation of continuous pores membrane by treating liquid medium containing protien with reactant |
| 07/13/1991 | WO1991010424A1 Method of inhibiting angiogenesis of tumors |
| 07/13/1991 | WO1991010422A1 Interdigitation-fusion liposomes and gels |
| 07/13/1991 | CA2050290A1 Method of inhibiting angiogenesis of tumors |
| 07/12/1991 | WO1991010506A1 Aqueous core microcapsules and method for their preparation |
| 07/12/1991 | CA2073685A1 Aqueous core microcapsules and method for their preparation |
| 07/12/1991 | CA2033914A1 Compressed confectionery tablets with at least two phases and sequential flavor delivery system |
| 07/11/1991 | WO1991009731A1 Nicotine packaging materials |
| 07/11/1991 | WO1991009641A1 Fibrin sealant delivery method |
| 07/11/1991 | WO1991009634A1 Rolipram-containing composition for transdermal application |
| 07/11/1991 | WO1991009629A1 Liposomes as contrast agents for ultrasonic imaging |
| 07/11/1991 | WO1991009617A1 Insulin preparations containing nicotinic acid or nicotinamide |
| 07/11/1991 | WO1991009616A1 Quinolone antibiotics encapsulated in lipid vesicles |
| 07/11/1991 | WO1991009609A1 Method and composition for treating xerostomia |
| 07/11/1991 | WO1991009606A1 Freeze-dried dosage forms and methods for preparing the same |
| 07/11/1991 | WO1991009599A1 Smoking substitute |
| 07/11/1991 | WO1991009592A1 Transdermal system |
| 07/11/1991 | WO1991009591A1 Preparation of pharmaceutical and other matrix systems by solid-state dissolution |
| 07/11/1991 | WO1991009590A1 Pharmaceutical preparation of et18-och3 for intravenous administration |
| 07/11/1991 | WO1991009525A1 Quinolone carboxylic acid--metal ion--acid complexes |
| 07/11/1991 | DE4000155A1 Pressed tablet for oral admin. with non-retarded release of agent - comprises homo and/or copolymer of D-(-)-3-hydroxybutyric acid, disintegrating and active-agents and has good storage stability |
| 07/11/1991 | CA2070814A1 Insulin preparations containing nicotinic acid or nicotinamide |
| 07/11/1991 | CA2033726A1 Topical compositions |
| 07/11/1991 | CA2028344A1 Method and apparatus to prepare extruded particles |
| 07/10/1991 | WO1991010423A1 Long-term delivery device including loading dose |
| 07/10/1991 | EP0436450A1 Magnetisable core-shell microspheres based on crosslinked organopolysiloxane, their preparation process and their biological use |
| 07/10/1991 | EP0436449A1 Magnetisable microspheres based on polysilsesquioxane, their preparation process and their biological use |
| 07/10/1991 | EP0436428A1 Controlled release device and process for preparing it |
| 07/10/1991 | EP0436373A1 Process for making tablets containing spray-dried naproxen or naproxen sodium |
| 07/10/1991 | EP0436370A1 Controlled release pharmaceutical preparation and method for producing the same |
| 07/10/1991 | EP0436353A1 Apparatus for the aerosol administration of medication |
| 07/10/1991 | EP0436284A1 Stable oral composition of zinc |
| 07/10/1991 | EP0436252A1 Pharmaceutical preparation for oral administration in fluid form |
| 07/10/1991 | EP0436217A2 Anti-inflammatory analgesic patch |
| 07/10/1991 | EP0436203A2 Percutaneous gel preparation |
| 07/10/1991 | EP0436110A1 Pankreatin preparations |
| 07/10/1991 | EP0436061A1 Bowel lavage composition |
| 07/10/1991 | EP0435944A1 Water purifying system |
| 07/10/1991 | EP0435913A1 Effervescent tablet. |
| 07/10/1991 | CN1052858A New xanthine derivatives |
| 07/10/1991 | CN1052789A Preparing process of salve for treating burns |
| 07/10/1991 | CN1052788A Controlled release pharmaceutical preparation and method for producing the same |
| 07/10/1991 | CN1052785A Veterinary devices |
| 07/10/1991 | CN1052777A Multiple encapsulated sweetener delivery system and method of preparation |
| 07/10/1991 | CA2033870A1 Oral pharmaceutical compositions in unit dosage form |
| 07/09/1991 | WO1991010425A1 Cell capsule extrusion systems |
| 07/09/1991 | US5030645 Method of treating asthma using (S)-α-fluoromethyl-histidine and esters thereof |
| 07/09/1991 | US5030632 Low dose temazepam |
| 07/09/1991 | US5030629 Compositions and method comprising heterocyclic compounds containing two heteroatoms as membrane penetration enhancers |
| 07/09/1991 | US5030457 Bioerodible polymers useful for the controlled release of therapeutic agents |
| 07/09/1991 | US5030456 Dosage form for treating cardiovascular diseases |
| 07/09/1991 | US5030455 Water-soluble drug; vegetable or synthetic oil; stearic acid, a stearate of glycerin, hydrogenated castor oil, stearyl alcoh ol or a fatty acid sucrose ester |
| 07/09/1991 | US5030454 Confining drugs in biodegradable polymer |
| 07/09/1991 | US5030453 Stable plurilamellar vesicles |
| 07/09/1991 | US5030452 Dispensing devices powered by lyotropic liquid crystals |
| 07/09/1991 | US5030447 Pharmaceutical compositions having good stability |
| 07/09/1991 | US5030442 Complex with amphipathic compound and lipid, topical, treatment of alopecia |
| 07/09/1991 | US5030441 Oxidation of ferrous to ferric hydroxide; cancer and rheumatoid arthritis treatment |
| 07/09/1991 | US5030391 Coating with shell of polymer material; baking to decompose shell; large particle size |
| 07/09/1991 | US5030216 Osmotically driven syringe |